Taxis Pharmaceuticals
2009
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Angel
LATEST DEAL TYPE
$1.14M
LATEST DEAL AMOUNT
Description
Developer of antibiotics and antiviral drugs designed to address the global health crisis of antimicrobial resistance. The company's drugs are mostly antibiotics and therapeutic agents that employ novel mechanisms of action distinct from those currently in clinical use, enabling physicians to treat methicillin-resistant Staphylococcus aureus (MRSA) affected patients.
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 9 Deer Park Drive
- Suite J-15
- Monmouth Junction, NJ 08852
- United States
+1 (732) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Taxis Pharmaceuticals’s full profile, request a free trial.
Taxis Pharmaceuticals Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Angel (individual) | 09-Jan-2019 | $1.14M | 000.00 | Completed | Generating Revenue | |
| 4. Angel (individual) | 25-Sep-2017 | Cancelled | Generating Revenue | |||
| 3. Angel (individual) | 10-Mar-2017 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 2. Angel (individual) | 22-Jul-2015 | $2M | $8.5M | 000.00 | Completed | Generating Revenue |
| 1. Angel (individual) | 13-Apr-2015 | $6.5M | $6.5M | 0000 | Completed | Generating Revenue |
Taxis Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00 |
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Taxis Pharmaceuticals Executive Team (4)
Taxis Pharmaceuticals Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Christopher Cimarusti | Taxis Pharmaceuticals | Board Member | 000 0000 | |
| Edmond LaVoie Ph.D | Self | Co-Founder & Board Member | 000 0000 | |
| Ernest Mario Ph.D | Taxis Pharmaceuticals | Board Member | 000 0000 | |
| Gail McIntyre Ph.D | Self | Board Member | 000 0000 | |
| S. David Kimball Ph.D | Self | Board Member | 000 0000 |